Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 10(5): e0128318, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26024534

RESUMO

The aims of this study were to compare the steadiness index of spinal regions during single-leg standing in older adults with and without chronic low back pain (LBP) and to correlate measurements of steadiness index with the performance of clinical balance tests. Thirteen community-dwelling older adults (aged 55 years or above) with chronic LBP and 13 age- and gender-matched asymptomatic volunteers participated in this study. Data collection was conducted in a university research laboratory. Measurements were steadiness index of spinal regions (trunk, thoracic spine, lumbar spine, and pelvis) during single-leg standing including relative holding time (RHT) and relative standstill time (RST), and clinical balance tests (timed up and go test and 5-repetition sit to stand test). The LBP group had a statistically significantly smaller RHT than the control group, regardless of one leg stance on the painful or non-painful sides. The RSTs on the painful side leg in the LBP group were not statistically significantly different from the average RSTs of both legs in the control group; however, the RSTs on the non-painful side leg in the LBP group were statistically significantly smaller than those in the control group for the trunk, thoracic spine, and lumbar spine. No statistically significant intra-group differences were found in the RHTs and RSTs between the painful and non-painful side legs in the LBP group. Measurements of clinical balance tests also showed insignificant weak to moderate correlations with steadiness index. In conclusion, older adults with chronic LBP demonstrated decreased spinal steadiness not only in the symptomatic lumbar spine but also in the other spinal regions within the kinetic chain of the spine. When treating older adults with chronic LBP, clinicians may also need to examine their balance performance and spinal steadiness during balance challenging tests.


Assuntos
Dor Crônica/fisiopatologia , Dor Lombar/fisiopatologia , Equilíbrio Postural , Postura , Coluna Vertebral/fisiopatologia , Adulto , Idoso , Dor Crônica/patologia , Feminino , Humanos , Dor Lombar/patologia , Masculino , Pessoa de Meia-Idade , Coluna Vertebral/patologia
2.
Behav Brain Res ; 222(1): 1-9, 2011 Sep 12.
Artigo em Inglês | MEDLINE | ID: mdl-21435355

RESUMO

Gait disturbances similar to those of human Parkinson's disease (PD) can be observed in animals after administration of neurotoxin 6-hydroxydopamine (6-OHDA) to induce unilateral nigrostriatal dopamine depletion. However, the relationship between gait disturbances and dopamine depletion following 6-OHDA infusion has not been determined. The present study investigated the longitudinal changes of spatiotemporal gait patterns using a walkway system to acquire footprints and lateral limb images over a 6-week period following unilateral 6-OHDA injection into the medial forebrain bundle of rats. Our results indicated that hemiparkinsonian rats exhibited changes in gait patterns, as compared to normal controls, and pre-lesion levels, including a significantly decreased walking speed and step/stride length as well as an increased base of support and foot angle. The relative percentage of the gait cycle was also altered, showing an increase in the stance to swing ratio, which was more evident in the affected hindlimb. Time-course observations showed that these gait disturbances occurred as early as 4 days post-lesion and gradually increased up to 42 days post-injury. The extents of gait disturbances were compared with conventional apomorphine-induced turning behavior and akinesia bar tests, which were also apparent at 4 days post-lesion but remained relatively unchanged after 28 days. Our time-course gait analysis of a unilateral 6-OHDA rodent model provides insight into the compensatory changes of motor functions during the 6-week development of a nigrostriatal lesion, which might be useful for future objective assessment of novel treatments for human PD subjects.


Assuntos
Lateralidade Funcional/fisiologia , Transtornos Neurológicos da Marcha/etiologia , Oxidopamina/toxicidade , Transtornos Parkinsonianos/induzido quimicamente , Simpatolíticos/toxicidade , Análise de Variância , Animais , Apomorfina/farmacologia , Modelos Animais de Doenças , Progressão da Doença , Masculino , Feixe Prosencefálico Mediano/efeitos dos fármacos , Movimento/efeitos dos fármacos , Movimento/fisiologia , Transtornos Parkinsonianos/complicações , Desempenho Psicomotor/efeitos dos fármacos , Ratos , Ratos Wistar , Comportamento Estereotipado/efeitos dos fármacos , Fatores de Tempo , Tirosina 3-Mono-Oxigenase/metabolismo , Gravação de Videoteipe
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...